Shingrix linked to substantial reduction in diagnoses in the six years after people received the shot
Researchers have raised hopes for delaying dementia after finding that a recently approved shingles vaccine was linked to a substantial reduction in diagnoses of the condition in the six years after receiving the shot.
The discovery, based on US medical records, suggests that beyond the health benefits of preventing shingles, a painful and sometimes serious condition in elderly people, the vaccine may also delay the onset of dementia, the UK’s leading cause of death.
More Stories
Microsoft unveils chip it says could bring quantum computing within years
Ex-US security officials urge funding for science research to keep up with China
Virologist Wendy Barclay: ‘Wild avian viruses are mixing up their genetics all the time. It’s like viral sex on steroids’